Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
about
The Role of PPARs in CancerA retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor liSteroid Hormone Receptor Signals as Prognosticators for Urothelial TumorPPAR Gamma in Neuroblastoma: The Translational Perspectives of Hypoglycemic DrugsPeroxisome proliferator-activated receptor gamma ligand-induced growth inhibition of human hepatocellular carcinomaThe antidiabetic drug ciglitazone induces high grade bladder cancer cells apoptosis through the up-regulation of TRAILA novel mechanism of PPAR gamma induction via EGFR signalling constitutes rational for combination therapy in bladder cancerPioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic ratsPeroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.PPARgamma-independent induction of growth arrest and apoptosis in prostate and bladder carcinomaPPARgamma Ligand as a Promising Candidate for Colorectal Cancer Chemoprevention: A Pilot Study.A phase 1 study of efatutazone, an oral peroxisome proliferator-activated receptor gamma agonist, administered to patients with advanced malignancies.Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study.Targeting PPARγ Signaling Cascade for the Prevention and Treatment of Prostate Cancer.PPARgamma-regulated tight junction development during human urothelial cytodifferentiationCoffee component hydroxyl hydroquinone (HHQ) as a putative ligand for PPAR gamma and implications in breast cancer.Use of noninsulin anti diabetics for prevention and treatment of cancer- narrative review article.Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas.The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study.Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study.Effects of PPARgamma and combined agonists on the urinary tract of rats and other species.The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR).DNA damage in exfoliated cells and histopathological alterations in the urinary tract of mice exposed to cigarette smoke and treated with chemopreventive agents.Chemotherapeutic drugs induce PPAR-gamma expression and show sequence-specific synergy with PPAR-gamma ligands in inhibition of non-small cell lung cancerPPARgamma and Apoptosis in Cancer.Present concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer.PPAR Ligands for Cancer Chemoprevention.The Critical Role of PPARgamma in Human Malignant MelanomaRisk of bladder cancer among patients with diabetes treated with a 15 mg pioglitazone dose in Korea: a multi-center retrospective cohort study.Pathology of bladder cancer among diabetic patients undergoing radical cystectomy with a history of pioglitazone (Actos) usePPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors.Scientific Evidence and Controversies About Pioglitazone and Bladder Cancer: Which Lessons Can Be Drawn?Loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) is associated with progression of human urothelial carcinomas.Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future.Identification of novel potential genetic predictors of urothelial bladder carcinoma susceptibility in Pakistani population.Thermodynamics in cancers: opposing interactions between PPAR gamma and the canonical WNT/beta-catenin pathway.New insights into antidiabetic drugs: Possible applications in cancer treatment.PPARγ disease gene network and identification of therapeutic targets for prostate cancer.Rosiglitazone and retinoic acid inhibit proliferation and induce apoptosis in the HCT-15 human colorectal cancer cell lineEffect of ligand troglitazone on peroxisome proliferator-activated receptor gamma expression and cellular growth in human colon cancer cells.
P2860
Q21342955-E7F0A9A2-B86E-4A33-AAA3-B35A3E488334Q24806395-42D5EA90-2370-4D9D-95FB-B4557B496686Q26771960-1FFB1A8C-4CBF-4D64-839B-FDAB7A520750Q28066756-16685CD4-EFCA-45A8-8788-A1F8E6341718Q28366616-A9552EE8-092D-4716-BEC9-B007797DDC7DQ28478349-42F5AB9B-8A16-4F30-9D33-AFFA645D6B78Q28486089-050331FC-0F18-493D-A337-1D3B3BF4EEA7Q28580246-496CC16E-B321-40E1-9B3E-D2E556E5E55FQ33215831-9F955528-B62E-4916-9476-ABA4D1DE0252Q33235601-C3F9F0C0-4646-4618-9D41-1C6E725F9882Q34089258-1AA8756E-559E-4099-B38F-7D8B82F31D1CQ34262817-C430EEC6-3B25-4BDA-8744-4CD6DC3C9633Q34628009-9655BE61-E464-4C2A-B48E-B54B19463847Q34646050-D7DDBE77-9D13-4FDB-9C6D-4F0EAFFD873EQ34863027-B8B3CAAE-0182-44D8-8EA1-F1CEE94CD28FQ35101709-EDEBA8B8-0CE0-4C11-8C29-32003FC5B75AQ35466765-087FCDD8-C8C8-43D6-92A8-157CD673E826Q35745965-F8B32A1D-AF39-4870-B111-A03D980642A7Q36001145-52A686F9-C649-4216-9486-70196F293B52Q36013549-C795CB34-52E5-44D5-987B-22272F7096EDQ36210174-B906BDB4-476A-4931-B621-4E97C5399733Q36328530-98C8832C-37ED-441C-A2A9-353F70437CD0Q36499766-8565437B-14BD-4298-BC5C-3A6E386F4786Q36661722-618FE2A6-DE99-4342-868F-85849A762777Q36742811-68AF0A5E-3F5C-4AC5-9624-92EE37DF3C2DQ36795404-0B5BDFFB-1115-4214-AA68-1D61316D7252Q37165190-0BE3EF11-AE23-4583-88D6-1BA173BE8804Q37165194-50170D3A-6422-4399-B7ED-F86B5C38E95CQ37583052-2A13708F-6FA6-4300-902E-29A871644664Q37607679-5D3EBFF7-A1D9-4D78-8313-850A5E4D5DEAQ37719276-E46DF776-81AB-4E92-AA16-AD360CF78059Q38122640-3A951B3A-CC49-410D-AE1C-44380DF9B4AFQ38329996-00DC49E7-367F-4D7D-9109-FAD36741939BQ38641190-0659B701-7B1B-4ABE-B7C6-CB5DEA1DE3A1Q38848728-C59B612B-B7AB-45FC-AE86-CDF4196CF226Q39239818-454E3E3F-531C-485C-9721-CEC423E55F91Q39272833-5B51C09C-B1CF-445B-A82C-E1B95C90F907Q39502492-378B2DF6-EDE8-41A8-9C64-A7C4746919D4Q39551235-D8B6F5C9-480A-4292-BFA6-CEAE538FDCE1Q40201153-68ED37ED-7BC1-4FCD-8A35-A66A5E003DC2
P2860
Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Expression of peroxisome proli ...... s role in inducing cell death.
@en
type
label
Expression of peroxisome proli ...... s role in inducing cell death.
@en
prefLabel
Expression of peroxisome proli ...... s role in inducing cell death.
@en
P2093
P2860
P356
P1433
P1476
Expression of peroxisome proli ...... s role in inducing cell death.
@en
P2093
P2860
P304
P356
10.1038/SJ.NEO.7900050
P577
1999-10-01T00:00:00Z